España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Amgen
AMGN
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$336.00
4.71
1.42%
Pre-Market: 12:51 AM EDT
15 minutes delayed
Get Report
Comment
Amgen (AMGN) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Amgen (NASDAQ:AMGN) Stock
Amgen Stock (NASDAQ: AMGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, July 19, 2024
Amgen Says Currently Assessing Global IT Outa...
Benzinga Newsdesk
Thursday, July 18, 2024
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Piero Cingari
Tuesday, July 16, 2024
Unpacking the Latest Options Trading Trends in Amgen
Benzinga Insights
Monday, July 15, 2024
A Closer Look at Amgen's Options Market Dynamics
Benzinga Insights
Friday, July 12, 2024
Live On CNBC, Kevin Simpson Announces Bought ...
Benzinga Newsdesk
Thursday, July 11, 2024
Check Out What Whales Are Doing With AMGN
Benzinga Insights
Morgan Stanley Maintains Equal-Weight on Amge...
Benzinga Newsdesk
Wednesday, July 10, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Sunday, July 07, 2024
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
Piero Cingari
Wednesday, July 03, 2024
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
Piero Cingari
Tuesday, July 02, 2024
What the Options Market Tells Us About Amgen
Benzinga Insights
Monday, July 01, 2024
Amgen Unusual Options Activity
Benzinga Insights
Thursday, June 27, 2024
Argus Research Maintains Buy on Amgen, Raises...
Benzinga Newsdesk
Tuesday, June 25, 2024
Smart Money Is Betting Big In AMGN Options
Benzinga Insights
Monday, June 24, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Friday, June 21, 2024
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
Vandana Singh
Tuesday, June 18, 2024
Check Out What Whales Are Doing With AMGN
Benzinga Insights
Friday, June 14, 2024
Amgen Announces FDA Approval Of BLINCYTO In C...
Benzinga Newsdesk
Expert Ratings For Amgen
Benzinga Insights
RBC Capital Maintains Outperform on Amgen, Ra...
Benzinga Newsdesk
Wednesday, June 12, 2024
Decoding Amgen's Options Activity: What's the Big Picture?
Benzinga Insights
Thursday, June 06, 2024
Market Whales and Their Recent Bets on AMGN Options
Benzinga Insights
Wednesday, June 05, 2024
Amgen To Present At Goldman Sachs 45th Annual...
Benzinga Newsdesk
Amgen Seeks Expanded US Approval For Autoimmune Disease Drug Acquired Via $28B Horizon Deal
Vandana Singh
Amgen Announces Phase 3 Trial Results For UPL...
Benzinga Newsdesk
Friday, May 31, 2024
Here's How Much You Would Have Made Owning Amgen Stock In The Last 20 Years
Benzinga Insights
Wednesday, May 29, 2024
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
Vandana Singh
Friday, May 24, 2024
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Vandana Singh
Tuesday, May 21, 2024
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
Piero Cingari
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $5,700 Today
Benzinga Insights
Alvotech And Dr. Reddy's Enter Collaboratoin ...
Benzinga Newsdesk
Monday, May 20, 2024
Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population
Vandana Singh
Reported Sunday, AstraZeneca And Amgen's TEZS...
Benzinga Newsdesk
Saturday, May 18, 2024
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
Nicolás Jose Rodriguez
Friday, May 17, 2024
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
Zacks
Amgen Unusual Options Activity
Benzinga Insights
FDA Gives Accelerated Approval To Amgen's Drug For Small Cell Lung Cancer Patients
Vandana Singh
Reported Earlier, FDA Approves Amgen's IMDELL...
Benzinga Newsdesk
Thursday, May 16, 2024
Watching Amgen; Hearing Co Wins U.S. Approval...
Benzinga Newsdesk
Wednesday, May 15, 2024
S&P 500, Nasdaq 100, Dow Jones Shatter Record Highs In Unstoppable Bull Market Rally
Piero Cingari
Should You Hold Viking Therapeutics in Your Portfolio?
Zacks
Tuesday, May 14, 2024
'Lawmaker accuses Amgen of placing profits ab...
Benzinga Newsdesk
Thursday, May 09, 2024
Trade Desk To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
Mizuho Maintains Neutral on Amgen, Raises Pri...
Benzinga Newsdesk
Wall Street Stares At Weaker Open On Rate Anxiety, Hopes For Better Earnings: Analyst Pencils Key S&P 500 Support Level
Shanthi Rexaline
Wednesday, May 08, 2024
Market Whales and Their Recent Bets on AMGN Options
Benzinga Insights
Tuesday, May 07, 2024
How Is The Market Feeling About Amgen?
Benzinga Insights
Monday, May 06, 2024
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Avi Kapoor
Amgen CEO Robert Bradway, On Innovation In He...
Benzinga Newsdesk
Check Out What Whales Are Doing With AMGN
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
